Introduction
Kawasaki disease (KD) is an acute systemic vasculitis of small and medium vessels that occur mainly in children. It manifests as febrile syndrome combined with data of vasculitis and can cause abnormalities in the coronary arteries in 25% of untreated patients [1] [2] [3] . Its incidence is higher in children under 5 years old, and the highest number of cases occurs in the winter and spring seasons [1] [2] [3] [4] [5] . The incidence of the disease is not well known. In Japan, 218 cases have been reported for every 100,000 children under 5 years old 6 ; in the U.S., 20 cases per year per 100,000 children; and in some Latin American countries, 11 annual cases per 100,000 children under 5 years old. In Mexico, the actual incidence is not known since there is only a report of some series of cases of the disease 4, [7] [8] [9] [10] [11] . The etiology is not clearly defined, but it is believed that there are triggers in genetically susceptible individuals that precipitate the cascade of inflammatory events that give rise to the disease [12] [13] [14] [15] [16] . The absence of specific laboratory tests makes the diagnosis a clinical challenge. Therefore, it is based on the criteria proposed by Kawasaki, which were later confirmed by the American Heart Association (AHA) 5 . There are also supplementary laboratory criteria, which are not specific, but are useful when the patient has clinical characteristics that are suggestive, but not diagnostic, of the disease (incomplete) 5, 17 . During the acute phase of the disease, there are infiltration and inflammation of cardiac cells that can generate coronary, myocardial, valvular, and pericardial affection. These alterations are presented in > 40% of patients 2 . Therefore, they must be intentionally evaluated with a two-dimensional echocardiogram, which should be performed at the time of diagnosis 18 . Some predictors of coronary disease have been identified, such as an incomplete presentation of the disease, male sex, age younger than 1 year or older than 5 years, and fever for 6 days or longer. The Harada score identifies patients with KD and high risk of developing coronary aneurysms; this classification considers risk when the score is ≥ 4 2,4,5 . The low clinical suspicion of the disease continues to delay the diagnosis and, with it, the increase in the risk of cardiovascular complications 19 . It is essential to know how the condition is expressed among different ages and different regions of the country. This study aimed to describe the clinical behavior and the recognition of risk factors for cardiovascular complications in pediatric patients with KD treated in the second level hospital in northwestern Mexico.
Methods
After the authorization by the local ethics and research committee, a case study was conducted with pediatric patients diagnosed with KD, treated at the second level care hospital in northwestern Mexico, between January 2013 and July 2016. The variables studied were cardiovascular complications (present or absent and type of condition), clinical behavior (complete presentation, incomplete, and atypical manifestations), Harada score, sex, age, leukocyte count, hemoglobin (Hb), mean corpuscular volume, platelet count, C-reactive protein (CRP), erythrocyte sedimentation rate (ESR), serum albumin values, erythrocyturia, pyuria, cylindruria, alanine aminotransferase (ALT), aspartate aminotransferase (AST), urea, creatinine, nutritional status (eutrophic, overweight, obesity, and severe obesity), season of the year in which the disease was diagnosed (spring, summer, autumn, or winter), treatment (adequate or inadequate), and proteinuria (positive or negative). A cell count > 15,000/mm 3 was considered leukocytosis. A platelet count > 4,50,000/mm 3 the presence of ≥ 5 erythrocytes (RBC) per high power field in the urinary sediment; leukocyturia, as the presence of > 5 leukocytes per high power field in urinary sediment; and ALT and AST, as serum values higher than 40 U/I.
The disease was classified according to the clinical criteria of presentation: as complete KD when fever of > 5 days of evolution persists and at least four of the following criteria: (1) changes in the extremities; (2) polymorphic rash; (3) bilateral bulbar conjunctival injection without exudate; (4) changes in the lips and oral cavity; and (5) acute non-purulent lymphadenopathy. If < 4 criteria are met, and coronary alterations are detected in the echocardiogram, it is considered as incomplete KD. If the patients presented renal changes (proteinuria, erythrocyturia, cylindruria, leukocyturia, sterile pyuria, and elevated nitrogen compounds), gastrointestinal alterations (diarrhea, vomiting, and abdominal pain), hepatic alterations (hyperbilirubinemia, hypertransaminasemia, and hypoalbuminemia), or neurological alterations (extreme irritability, aseptic meningitis, and neurosensory loss), these were classified as atypical or uncommon manifestations.
The extent of the fever (in days) was also assessed, as well as cardiovascular complications integrated by echocardiography (coronary dilatation with an internal diameter > 2.5 mm, small coronary aneurysm if measured < 5 mm, medium between 5 and 8 mm, and giant if measured > 8 mm). Furthermore, the treatment received and the time of evolution of the disease in which it was administered, as well as the Harada score of each of the patients to estimate the risk of developing coronary aneurysms.
According to the treatment, the administration of salicylates, glucocorticoids, and immunoglobulin was considered, dividing the latter into three groups: (1) early administration, those who received 2 g/kg in continuous infusion of 12 h before 10 days of evolution, (2) late administration, who received 2 g/kg after 10 days of evolution, and (3) those who did not receive immunoglobulin or in whom the dose was fractionated.
Data collected were transferred to an electronic database and analyzed using the Statistical Package for Social Science version 2.0. Descriptive statistics were used. The qualitative variables were described in measures of frequency (percentages), medians and interquartile ranges for quantitative variables, and determination of the odds ratio (OR) RM to determine the risk. The χ 2 test determined the association between qualitative variables.
Results
We studied 12 patients, eight females and four males (ratio 2:1), whose median age was 2.05 years; four (33%) patients were under 2 years old, and eight (67%) were between 2 and 3.5 years (Table 1) .
Regarding the phase of the disease at the time of diagnosis, eight patients (67%) were diagnosed in the acute phase and four (33%) in the subacute phase. The spell of the fever was variable, with a median of 9.5 days. The fever lasted 10 or more days in six (50%) of the cases 6 (Table 1) .
The clinical behavior at the time of diagnosis was complete KD in 100% of the cases; also, all presented atypical manifestations (also called uncommon) ( Table 1) . Table 2 describes the typical and atypical clinical signs found in this group of patients. Laboratory abnormalities found most frequently were leukocytosis in 75% of patients, thrombocytosis in 67%, and hypoalbuminemia and elevated AST in 50% of patients. Regarding the analysis of urinary sediment, 33.3% of the patients presented hyaline cylinders, 25% proteinuria, pyuria, and erythrocyturia, and 16.6% granular cylinders.
About the treatment, 10 patients (83%) were given an adequate treatment, of which three were given the second dose of immunoglobulin for the persistence of fever. The 12 patients were given salicylates, and only one received glucocorticoids.
Cardiovascular complications were found in six (50%) of the patients, three (3/8) females and three (3/4) males. Table 3 describes in detail the characteristics of this group of patients.
Of the patients with cardiovascular complications, the coronary disease was found in four (67%): two presented dilation of the left coronary artery and one of the right coronary artery, and one presented aneurysm in both coronary arteries of medium size. Table 4 shows the association of some laboratory alterations with the presence of cardiovascular complications; stand out erythrocyturia and anemia, with a probability (p) of 0.09 and 0.12, respectively. The risk for cardiovascular complications was estimated, and an OR of 10 was determined for anemia; for ages under 2 years, male sex and presence of hyaline cylinders, an OR of 5 was determined (Table 4) . Table 5 describes the medians and interquartile ranges for age, days of fever, and laboratory results in patients with and without cardiovascular complications; the average of Hb was 9.5 in patients with complications versus 11.25 in patients without complications. 
Discussion
In this study, the predominance of female sex was found, with a male:female ratio of 1:2, different from that reported by Sotelo-Cruz 2 , who found a predominance of male sex in a 3.3:1 ratio. Cases were more frequent in children under 2 years old, different from that reported by national series in which patients between 3 and 5 years of age predominated 2, 3, 20 .
According to the season, half of the cases took place in winter and only one-third in spring, which differs from that reported in national studies, in which a higher frequency of cases was determined in the spring 3 . The majority of patients were detected during the acute phase, with an average fever of 9.5 days, which is similar to that reported by Morales-Quispe et al. 20 It is very close to the limit of what is recommended by the AHA to reduce the risk of coronary complications 7 .
Regarding clinical behavior, all patients met the criteria to define complete KD, similar to that found in the most extensive series published in Mexico 2,6,11 . Similarly, all the patients presented atypical manifestations, a higher proportion than that reported in other series 2, 3, 6, 9, 20, 21 . The most common atypical (uncommon) symptoms were gastrointestinal (abdominal pain and diarrhea), respiratory (cough), and joint aching (arthralgias), similar to Sotelo-Cruz 2 , who found a predominance of joint pain, hepatomegaly, cough, abdominal pain, nausea, and vomiting. ALT: alanine aminotransferase; AST: aspartate aminotransferase; CI: confidence interval; CRP: C-reactive protein; OR: odds ratio; ESR: erythrocyte sedimentation rate, p: probability calculated by Fisher's exact test.
The most frequent laboratory alterations were leukocytosis, thrombocytosis, hypoalbuminemia, and elevated AST, which have been observed in the majority of published studies. CRP was elevated in all patients, but in all cases it was under 3 mg/dL.
All patients received intravenous immunoglobulin (2 g/kg). Most of them received adequate treatment with early immunoglobulin and salicylates; only two patients received late immunoglobulin treatment and one patient required glucocorticoid for the fever persistence. These three patients presented coronary alterations, which are related to that reported by Garrido-García et al. 6 In that series of cases, patients who received intravenous immunoglobulin after day 10 of evolution and the one who received glucocorticoids presented coronary alterations; two patients showed coronary dilation, and one, an aneurysm of both coronary arteries. Of these, only the one that received glucocorticoids presented a positive Harada score. Furthermore, 50% of the patients in this series presented echocardiography alterations, percentage higher than the 32% reported by Sotelo-Cruz 2 , the 29.4% reported by García-Rodríguez et al. 11 , and the 35% reported by Surjit et al. 22 However, it was similar to the 54% reported by Gil-Veloz et al. 3 Our results may have been influenced by the characteristics of the patients in our series since there is female predominance, the median age is 2.1 years (lower than that reported in other series), 2, 3, 20 and there is a high frequency of atypical manifestations.
Of the patients with echocardiographic alterations, 50% were female. However, more cardiovascular complications were observed in males (75%) than in females (38%). Regarding age, 50% of the patients with cardiovascular complications were younger than 2 years; the other 50% was between 2 and 3.5 years old.
Within the laboratory parameters, a 10-time higher risk of developing cardiovascular complications was found in patients who had anemia, and 5 times higher in male patients with hyaline cylinders in the urinary sediment and those under 2 years of age. Elevation of CRP and ESR, a leukocyte count > 12,000, low Hb values, a hematocrit of < 35%, decreased serum albumin, elevated transaminases, and hyponatremia have been reported in other publications as risk factors for presenting cardiovascular complications 23 . The median Hb in patients with cardiovascular complication was 9.6 versus 11.25 in patients without complications. These results are similar to those by Caballero-Mora et al. 23 , who reported a mean Hb of 10.3 in patients with complications and 11.42 in patients without Early detection is crucial to avoid cardiovascular complications. In this series, most patients were adequately treated, and cardiovascular complications occurred in half of the cases: 33% corresponded to coronary disease, similar to that reported in other national series. 3, 6 In Japan, a decrease in cardiovascular consequences (coronary aneurysms and myocardial infarctions) has been observed thanks to the detection during the acute phase of the disease and its adequate management 9 . As reported by Gil-Veloz et al. 3 and Morales-Quispe et al. 20 , the early administration of gamma-globulin during the first day of the disease reduces the risk of cardiovascular complications, especially residual aneurysms.
Although the risk of erythrocyturia for the development of cardiovascular complications has not been reported, as was found in our study, the association of this sign or others should be studied further in more extensive series of patients to improve the prediction of risk complications and timely treatment.
Furthermore, the classification according to the criteria of the AHA is limiting since the frequency of atypical or incomplete course is high, as observed in this series and other reports 24 . Therefore, the classification of the disease according to standard criteria results problematic.
The variability in the presentation of the symptoms requires a more significant number of research studies that allow knowing how the disease manifests under different sociodemographic and geographical conditions.
We recognize limitations on our study because there are possibilities of affecting the information contained in the files despite the efforts to overcome the selection and information biases. Besides, the sample size is small, which weakens the power of the statistical analysis. Multicenter studies are suggested for larger samples, with robust statistical analysis and the possibility of generalization of the results.
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